Doribax and Hypotension - a phase IV clinical study of FDA data
Hypotension is reported only by a few people who take Doribax.
The phase IV clinical study analyzes which people take Doribax and have Hypotension. It is created by eHealthMe based on reports of 294 people who have side effects while taking Doribax from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
294 people reported to have side effects when taking Doribax.
Among them, 5 people (1.7%) have Hypotension.
What is Doribax?
Doribax has active ingredients of doripenem. eHealthMe is studying from 296 Doribax users for its effectiveness, alternative drugs and more.
What is Hypotension?
Hypotension (abnormally low blood pressure) is found to be associated with 4,028 drugs and 4,489 conditions by eHealthMe.
Number of Doribax and Hypotension reports submitted per year:
Gender of people who have Hypotension when taking Doribax *:
- female: 20 %
- male: 80 %
Age of people who have Hypotension when taking Doribax *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Doribax *:
- Fluconazole: 2 people, 40.00%
- Simvastatin: 2 people, 40.00%
- Ranitidine: 2 people, 40.00%
- Ventolin: 2 people, 40.00%
- Isoniazid: 2 people, 40.00%
- Folic Acid: 2 people, 40.00%
- Warfarin Sodium: 1 person, 20.00%
- Amikacin Sulfate: 1 person, 20.00%
- Aspirin: 1 person, 20.00%
- Celecoxib: 1 person, 20.00%
Common side effects people have besides Hypotension *:
- Loss Of Consciousness: 2 people, 40.00%
- Urine Output - Decreased: 1 person, 20.00%
- Swallowing Difficulty: 1 person, 20.00%
- Septic Shock (shock due to blood infection): 1 person, 20.00%
- Renal Impairment (severely reduced kidney function): 1 person, 20.00%
- Liver Disorder (liver diseases): 1 person, 20.00%
- High Blood Pressure: 1 person, 20.00%
- Heart Rate Increased: 1 person, 20.00%
- Haematocrit Decreased: 1 person, 20.00%
- Depressed Level Of Consciousness: 1 person, 20.00%
Common conditions people have *:
- Nosocomial Infection (infection from hospital): 2 people, 40.00%
- Sedation: 1 person, 20.00%
- Pneumonia: 1 person, 20.00%
- Phantom Pain: 1 person, 20.00%
- Lymphoma (cancer that begins in immune system cells): 1 person, 20.00%
- High Blood Pressure: 1 person, 20.00%
- Brain Abscess: 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Doribax and have Hypotension?Check whether Hypotension is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Doribax:
- Doribax (296 reports)
Hypotension treatments and more:
- Hypotension (266,572 reports)
COVID vaccines that are related to Hypotension:
- Hypotension in Moderna COVID Vaccine
- Hypotension in Pfizer BioNTech Covid Vaccine
- Hypotension in Johnson and Johnson Covid Vaccine
How severe was Hypotension and when was it recovered:
Expand to all the drugs that have ingredients of doripenem:
Common drugs associated with Hypotension:
All the drugs that are associated with Hypotension:
- Hypotension (4,028 drugs)
Common conditions associated with Hypotension:
All the conditions that are associated with Hypotension:
- Hypotension (4,489 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on doripenem (the active ingredients of Doribax) and Doribax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.